NYSEMKT: ARMP
Armata Pharmaceuticals Inc Earnings Dates, Reports, Calls

Armata Pharmaceuticals earnings were -$46.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest ARMP earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$26.7M, up 63.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARMP reported annual earnings of -$18.9M, with -72.6% growth.

ARMP earnings history

Current Revenue
$1.2M
Current Earnings
-$46.9M
Current Profit Margin
-3,797.7%

ARMP Return on Equity

Current Company
N/A
Current Industry
-21.2%
Current Market
35.8%

ARMP undefined

Current Company
-54.5%
Current Industry
-8.7%
ARMP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ARMP announces earnings.

ARMP undefined

Current Company
63.18%
Current Industry
-3.4%
ARMP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARMP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ARMP-$30.37M-$46.90MN/A-$1.29
SGMT-$57.52M-$57.67MN/A-$1.78
NBY$3.47M$3.24MN/A$2.33
IMMX-$23.21M-$23.56MN/A-$0.77
STTK-$50.69M-$54.90MN/A-$1.02

Armata Pharmaceuticals Earnings Reports & History FAQ

What were Armata Pharmaceuticals's earnings last quarter?

On ARMP's earnings call on Invalid Date, Armata Pharmaceuticals (NYSEMKT: ARMP) reported Q3 2025 earnings per share (EPS) of -$0.74, up 393.33% year over year. Total ARMP earnings for the quarter were -$26.68 million. In the same quarter last year, Armata Pharmaceuticals's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.

Is Armata Pharmaceuticals profitable or losing money?

As of the last Armata Pharmaceuticals earnings report, Armata Pharmaceuticals is currently losing money. Armata Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$46.90 million, a 13.39% increase year over year.

What was ARMP's earnings growth in the past year?

As of Armata Pharmaceuticals's earnings date in Invalid Date, Armata Pharmaceuticals's earnings has grown year over year. ARMP earnings in the past year totalled -$46.90 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.